Detection of anti-CUEC-23 antibodies in serum of patients with esophageal squamous cell carcinoma : a possible new serum marker for esophageal cancer
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-07-01
著者
-
Matsubara H
Department Of Frontier Surgery Graduate School Of Medicine Chiba University
-
Matsubara Hisahiro
Department Of Frontier Surgery Chiba University Graduate School Of Medicine
-
Matsubara Hiromasa
Second Department Of Surgery Chiba University School Of Medicine
-
Shimada Hideaki
Department of Tissue and Organ Development, Regeneration and Advanced Medical Science, Gifu Universi
-
Shimada Hideaki
千葉大学 医学研究院先端応用外科学
-
Shimada H
Department Of Frontier Surgery Graduate School Of Medicine Chiba University
-
Matsubara Hisahiro
Department Of Academic Surgery Graduate School Of Medicine Chiba University
-
Shiina Hiroyuki
Department Of Pharmacology Toho University Faculty Of Pharmaceutical Sciences
-
Shimada Hideaki
Department Of Gastroenterological Surgery Chiba Cancer Center
-
SHIRATORI Tooru
Department of Frontier Surgery, Chiba University Graduate School of Medicine
-
HIWASA TAKAKI
Department of Biochemistry (I), Chiba University School of Medicine
-
Hiwasa Takaki
Department Of Biochemistry And Genetics Chiba University Graduate School Of Medicine
-
Shiratori Tooru
Department Of Frontier Surgery Chiba University Graduate School Of Medicine
-
KAGAYA Akiko
Department of Frontier Surgery, Chiba University Graduate School of Medicine
-
NOMURA Fumio
Department of Molecular Diagnosis, Chiba University Graduate School of Medicine
-
TAKIGUCHI Masaki
Department of Biochemistry and Genetics, Chiba University Graduate School of Medicine
-
Shimada H
Kumamoto Univ. Kumamoto
-
Shimada Hideaki
Department Of Pharmacology Toho University Faculty Of Pharmaceutical Science
-
Kagaya Akiko
Department Of Frontier Surgery Chiba University Graduate School Of Medicine
-
Takiguchi Masaki
Department Of Biochemistry And Genetics Chiba University Graduate School Of Medicine
-
Takiguchi Masaki
Department Of Biochemistry And Genetics (e1) Graduate School Of Medicine Chiba University
-
Shimada Hideaki
Department Of Frontier Surgery Chiba University Graduate School Of Medicine
-
Shimada Hideaki
Department Of Academic Surgery Graduate School Of Medicine Chiba University
-
Nomura Fumio
Department Of Molecular Diagnosis Chiba University Graduate School Of Medicine
-
Nomura Fumio
Department Of Molecular Diagnosis Graduate School Of Medicine Chiba University
-
Sakurai Haruna
Department Of Pharmacology School Of Pharmaceutical Sciences Showa University
-
Muramatsu Hisako
Department Of Frontier Surgery Chiba University Graduate School Of Medicine
-
Sashiyama Hiroshi
千葉大学 医学研究院先端応用外科学
-
Shimada Hideaki
Department Of Academic Surgery (m9) Graduate School Of Medicine Chiba University
-
Matsubara Hiromasa
Department Of Frontier Surgery (m9) Graduate School Of Medicine Chiba University
-
HIWASA TAKAKI
Department of Biochemistry and Genetics, Chiba University Graduate School of Medicine
-
Nomura Fumio
Department of Molecular Diagnosis (F8) Graduate School of Medicine, Chiba University
関連論文
- Differentiation of dopaminergic neurons from human embryonic stem cells : Modulation of differentiation by FGF-20(CELL AND TISSUE ENGINEERING)
- Human Arm protein lost in epithelial cancers, on chromosome X 1 (ALEX1) gene is transcriptionally regulated by CREB and Wnt/β-catenin signaling
- Multidetector-Row Computed Tomography Management of Acute Pulmonary Embolism
- Salvage Surgery for Esophageal Carcinoma after Definitive Chemoradiation Therapy
- Receptor-type protein tyrosine phosphatase ζ as a component of the signaling receptor complex for midkine-dependent survival of embryonic neurons
- Gender Differences in Chronic Thromboembolic Pulmonary Hypertension in Japan
- Dilatation of Bronchial Arteries Correlates With Extent of Central Disease in Patients With Chronic Thromboembolic Pulmonary Hypertension
- Survival and Quality of Life for Patients With Peripheral Type Chronic Thromboembolic Pulmonary Hypertension
- The Effects of Carbon Ion Irradiation Revealed by Excised Perforated Intestines as a Late Morbidity for Uterine Cancer Treatment
- Phase I/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinoma